Patents by Inventor Sandro Jose de Souza

Sandro Jose de Souza has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • CTSP cancer-testis antigens
    Patent number: 8470989
    Abstract: The invention relates to CTSP polypeptides and the nucleic acid molecules that encode them. The invention further relates to the use of the nucleic acid molecules, polypeptides and fragments thereof in methods and compositions for the diagnosis, prognosis and treatment of diseases, such as cancer. More specifically, the invention relates to the discovery of a novel cancer/testis (CT) antigen, CTSP-1.
    Type: Grant
    Filed: May 2, 2012
    Date of Patent: June 25, 2013
    Assignee: Ludwig Institute for Cancer Research
    Inventors: Raphael Bessa Parmigiani, Maria Dulcetti Vibranovski, Sandro José de Souza, Anamaria Aranha Camargo
  • CTSP CANCER-TESTIS ANTIGENS
    Publication number: 20120276147
    Abstract: The invention relates to CTSP polypeptides and the nucleic acid molecules that encode them. The invention further relates to the use of the nucleic acid molecules, polypeptides and fragments thereof in methods and compositions for the diagnosis, prognosis and treatment of diseases, such as cancer. More specifically, the invention relates to the discovery of a novel cancer/testis (CT) antigen, CTSP-1.
    Type: Application
    Filed: May 2, 2012
    Publication date: November 1, 2012
    Applicant: Ludwig Institute for Cancer Research Ltd.
    Inventors: Raphael Bessa PARMIGIANI, Maria Dulcetti Vibranovski, Sandro Jose de Souza, Anamaria Aranha Camargo
  • CTSP cancer-testis antigens
    Patent number: 8207300
    Abstract: The invention relates to CTSP polypeptides and the nucleic acid molecules that encode them. The invention further relates to the use of the nucleic acid molecules, polypeptides and fragments thereof in methods and compositions for the diagnosis, prognosis and treatment of diseases, such as cancer. More specifically, the invention relates to the discovery of a novel cancer/testis (CT) antigen, CTSP-1.
    Type: Grant
    Filed: January 29, 2007
    Date of Patent: June 26, 2012
    Assignee: Ludwig Institute for Cancer Research Ltd.
    Inventors: Raphael Bessa Parmigiani, Maria Dulcetti Vibranovski, Sandro Jose de Souza, Anamaria Aranha Camargo
  • Ctsp Cancer-Testis Antigens
    Publication number: 20090181021
    Abstract: The invention relates to CTSP polypeptides and the nucleic acid molecules that encode them. The invention further relates to the use of the nucleic acid molecules, polypeptides and fragments thereof in methods and compositions for the diagnosis, prognosis and treatment of diseases, such as cancer. More specifically, the invention relates to the discovery of a novel cancer/testis (CT) antigen, CTSP-1.
    Type: Application
    Filed: January 29, 2007
    Publication date: July 16, 2009
    Inventors: Raphael Bessa Parmigiani, Maria Dulcetti Vibranovski, Sandro Jose de Souza, Anamaria Aranha Camargo
  • Isolated protein having molecular weight of from about 55 kilodaltons to about 65 kilodaltons (SDS-page) which binds to prion protein
    Patent number: 5679530
    Abstract: The invention involves an isolated anti prion protein binding protein which has a molecular weight of from about 55 kD to about 65 kD as determined by SDS-PAGE. Also described is a peptide derived from this isolated anti-prion protein binding protein. Diagnostic uses for each of these molecules are discussed.
    Type: Grant
    Filed: April 12, 1995
    Date of Patent: October 21, 1997
    Assignee: Ludwig Institute for Cancer Research
    Inventors: Ricardo Renzo Brentani, Sandro Jose de Souza